TrialThe Lancet. Infectious diseases2025

Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial.

Richard Idro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.